<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="328">
  <stage>Registered</stage>
  <submitdate>30/08/2005</submitdate>
  <approvaldate>6/09/2005</approvaldate>
  <actrnumber>ACTRN12605000306617</actrnumber>
  <trial_identification>
    <studytitle>Cough and reflux</studytitle>
    <scientifictitle>Using a novel pH-cough meter to objectively study acid reflux and cough in children</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Cough</healthcondition>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2 />
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Use of pH-cough meter and proton pump inhibitor. 8 weeks for PPI.</interventions>
    <comparator />
    <control>Uncontrolled</control>
    <interventioncode>None</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Cough</outcome>
      <timepoint>Measured at baseline and end of 8 weeks.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Time relationship between cough and pH as recorded on pH-cough meter</outcome>
      <timepoint>Measured at baseline.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Cough sensitivity measures</outcome>
      <timepoint>Measured at baseline.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Bronchoalveolar markers</outcome>
      <timepoint>Measured at baseline.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Children referred togastroenterologists at the Royal Children'sHospital with suspected GORD and undergoing pHmetry. </inclusivecriteria>
    <inclusiveminage>6</inclusiveminage>
    <inclusiveminagetype>Months</inclusiveminagetype>
    <inclusivemaxage>14</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Contraindications for use of lansoprazole, clinical history of primary aspiration (neuromuscular problems,  suppurative lung disease, children receiving additional concomitant new therapy for any pulmonary disorder.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Diagnosis</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/10/2004</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>30</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Royal Children's Hospital</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Royal Children's Hospital Foundation</fundingname>
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Anne Chang</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Ria Halstead</name>
      <address>Department of Respiratory Medicine
Royal Children's Hospital
Herston QLD 4029</address>
      <phone>+61 7 36361956</phone>
      <fax>+61 7 36361958</fax>
      <email>ria_halstead@health.qld.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Anne B Chang</name>
      <address>Department of Respiratory Medicine
Royal Children's Hospital
Herston QLD 4029</address>
      <phone>+61 7 36369149</phone>
      <fax>+61 7 36361958</fax>
      <email>annechang@ausdoctors.net</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>